Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Cox

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|July 23, 2011
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progressionLatif A Wafa, Helen Cheng, Nathan Plaa, et al.
Journal of Biochemical and Molecular Toxicology|January 6, 2016
The Effects of the Organic Flame-Retardant 1,2-Dibromo-4-(1,2-dibromoethyl) Cyclohexane (TBECH) on Androgen Signaling in Human Prostate Cancer Cell LinesLilian I L Wong, Alexandra R Reers, Heidi A Currier, et al.
JBMR Plus|May 20, 2025
Denosumab treatment of giant cell tumors in the spine induces woven bone formationRobyn Birch, Felipe Eltit, Dennis Xie, et al.
Cancer Research|December 3, 2004
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression modelSandra L Krueckl, Robert A Sikes, N Magnus Edlund, et al.
The Journal of Biological Chemistry|December 15, 2005
Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophagesPooran Qasimi, Andrew Ming-Lum, Ali Ghanipour, et al.
The Prostate|September 12, 2008
Insulin receptor expression by human prostate cancersMichael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Molecular and Cellular Endocrinology|February 5, 2014
Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growthArio Takeuchi, Masaki Shiota, Eliana Beraldi, et al.
Gastrointestinal Endoscopy|September 15, 2015
Endoscopic management of colonic perforations: clips versus suturing closure (with videos)Sergey V Kantsevoy, Marianne Bitner, Gulara Hajiyeva, et al.
Cancer Research|May 3, 2006
Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cellsJerod Bertram, James W Peacock, Clara Tan, et al.
Human Pathology|September 26, 2006
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumorsLatif A Wafa, Jodie Palmer, Ladan Fazli, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|July 23, 2011
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progressionLatif A Wafa, Helen Cheng, Nathan Plaa, et al.
Journal of Biochemical and Molecular Toxicology|January 6, 2016
The Effects of the Organic Flame-Retardant 1,2-Dibromo-4-(1,2-dibromoethyl) Cyclohexane (TBECH) on Androgen Signaling in Human Prostate Cancer Cell LinesLilian I L Wong, Alexandra R Reers, Heidi A Currier, et al.
JBMR Plus|May 20, 2025
Denosumab treatment of giant cell tumors in the spine induces woven bone formationRobyn Birch, Felipe Eltit, Dennis Xie, et al.
Cancer Research|December 3, 2004
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression modelSandra L Krueckl, Robert A Sikes, N Magnus Edlund, et al.
The Journal of Biological Chemistry|December 15, 2005
Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophagesPooran Qasimi, Andrew Ming-Lum, Ali Ghanipour, et al.
The Prostate|September 12, 2008
Insulin receptor expression by human prostate cancersMichael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Molecular and Cellular Endocrinology|February 5, 2014
Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growthArio Takeuchi, Masaki Shiota, Eliana Beraldi, et al.
Gastrointestinal Endoscopy|September 15, 2015
Endoscopic management of colonic perforations: clips versus suturing closure (with videos)Sergey V Kantsevoy, Marianne Bitner, Gulara Hajiyeva, et al.
Cancer Research|May 3, 2006
Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cellsJerod Bertram, James W Peacock, Clara Tan, et al.
Human Pathology|September 26, 2006
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumorsLatif A Wafa, Jodie Palmer, Ladan Fazli, et al.
Pageof 7